A Pirzkall

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience
    Andrea Pirzkall
    Department of Clinical Radiology, University of Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 55:362-72. 2003
  2. ncbi Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors
    A Pirzkall
    Department of Clinical Radiology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 48:1371-80. 2000
  3. ncbi 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI
    Andrea Pirzkall
    Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA 94143 0226, USA
    Int J Radiat Oncol Biol Phys 59:126-37. 2004
  4. ncbi MR-spectroscopy guided target delineation for high-grade gliomas
    A Pirzkall
    Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA 94143 0226, USA
    Int J Radiat Oncol Biol Phys 50:915-28. 2001
  5. ncbi Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy
    Andrea Pirzkall
    Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA 94143, USA
    Int J Radiat Oncol Biol Phys 53:1254-64. 2002
  6. ncbi The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets
    Andrea Pirzkall
    Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA 94143 0226, USA
    Int J Radiat Oncol Biol Phys 53:434-42. 2002
  7. ncbi Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases
    A Pirzkall
    Department of Radiation Oncology, University of Heidelberg, Germany
    J Clin Oncol 16:3563-9. 1998
  8. ncbi Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma
    Antoinette A Chan
    Department of Radiology, University of California, San Francisco, California 94107-1739, USA
    J Neurosurg 101:467-75. 2004
  9. ncbi Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings
    Ilwoo Park
    Surbeck Laboratory of Advanced Imaging, Department of Radiology, University of California San Francisco, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 69:381-9. 2007
  10. ncbi Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM
    Forrest W Crawford
    Department of Radiology, University of California San Francisco, 1700 4th Street, San Francisco, CA 94143 2532, USA
    J Neurooncol 91:337-51. 2009

Detail Information

Publications25

  1. ncbi Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience
    Andrea Pirzkall
    Department of Clinical Radiology, University of Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 55:362-72. 2003
    ..To investigate the feasibility of using intensity modulated radiotherapy (IMRT) for complex-shaped benign meningiomas of the skull base and report clinical experience...
  2. ncbi Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors
    A Pirzkall
    Department of Clinical Radiology, University of Heidelberg, Heidelberg, Germany
    Int J Radiat Oncol Biol Phys 48:1371-80. 2000
    ..Conformal and intensity-modulated radiotherapy (IMRT) plans for 9 patients were compared based on characterization of plan quality and effects on the oncology department...
  3. ncbi 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI
    Andrea Pirzkall
    Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA 94143 0226, USA
    Int J Radiat Oncol Biol Phys 59:126-37. 2004
    ....
  4. ncbi MR-spectroscopy guided target delineation for high-grade gliomas
    A Pirzkall
    Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA 94143 0226, USA
    Int J Radiat Oncol Biol Phys 50:915-28. 2001
    ..We assessed the impact MRSI might have on the target volumes used for radiation therapy treatment planning for high-grade gliomas...
  5. ncbi Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy
    Andrea Pirzkall
    Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA 94143, USA
    Int J Radiat Oncol Biol Phys 53:1254-64. 2002
    ..We performed a study examining the impact MRSI would have on the routine addition of 2-3-cm margins around MRI T2-weighted hyperintensity to generate the treatment planning clinical target volume (CTV) for low-grade gliomas...
  6. ncbi The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets
    Andrea Pirzkall
    Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA 94143 0226, USA
    Int J Radiat Oncol Biol Phys 53:434-42. 2002
    ..To examine the influence of energy and number of beams on nontarget dose when using intensity-modulated radiation therapy (IMRT) to treat deep-seated targets...
  7. ncbi Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases
    A Pirzkall
    Department of Radiation Oncology, University of Heidelberg, Germany
    J Clin Oncol 16:3563-9. 1998
    ..Evaluation of the treatment outcome after radiosurgery (RS) alone or in combination with whole-brain radiotherapy (WBRT) with special attention to prescribed dose and its influence on local control and survival...
  8. ncbi Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma
    Antoinette A Chan
    Department of Radiology, University of California, San Francisco, California 94107-1739, USA
    J Neurosurg 101:467-75. 2004
    ..This difference was statistically significant (p < 0.01). CONCLUSIONS: Analysis of the results of this study indicates that patients undergoing GKS may benefit from the inclusion of 1H-MRS imaging in the treatment planning process...
  9. ncbi Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings
    Ilwoo Park
    Surbeck Laboratory of Advanced Imaging, Department of Radiology, University of California San Francisco, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 69:381-9. 2007
    ....
  10. ncbi Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM
    Forrest W Crawford
    Department of Radiology, University of California San Francisco, 1700 4th Street, San Francisco, CA 94143 2532, USA
    J Neurooncol 91:337-51. 2009
    ..These parameters may provide useful information for predicting outcome and for the stratification of patients into high or low risk groups for clinical trials...
  11. ncbi Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy
    Suja Saraswathy
    Department of Radiology and Biomedical Imaging, UCSF, Box 2532, Byers Hall, 1700 4th Street, San Francisco, CA, 94143 2532, USA
    J Neurooncol 91:69-81. 2009
    ..This information may be important for stratifying patients to specific treatment protocols and for planning focal therapy...
  12. ncbi Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy
    Anne Laprie
    Department of Radiology, University of California, San Francisco, San Francisco, CA 94107-1739, USA
    Int J Radiat Oncol Biol Phys 62:20-31. 2005
    ..Longitudinal multivoxel MRSI measurements have potential value in assessing response to radiation or other therapies, because they offer more coverage than single-voxel techniques and provide reliable spectral data...
  13. ncbi Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planning
    E E Graves
    Department of Radiology, University of California, San Francisco 94143, USA
    Med Phys 28:2489-96. 2001
    ..These images were sent via DICOM transfer to the treatment planning workstation. An analysis of the reproducibility of the..
  14. ncbi High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results
    J Debus
    Department of Radiation Oncology, University of Heidelberg, and Research Program, Radiological Diagnostics and Therapy, German Cancer Research Center, Heidelberg, Germany
    J Clin Oncol 19:3547-53. 2001
    ..We analyzed the long-term results of patients with skull-base meningiomas treated by a new approach with high-precision fractionated stereotactic radiotherapy...
  15. ncbi Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma
    Andrea Pirzkall
    Department of Radiology and Margaret Hart Surbeck Laboratory of Advanced Imaging, University of California, San Francisco, San Francisco, CA, USA
    Neuro Oncol 11:842-52. 2009
    ..The acquisition of metabolic and physiologic imaging data prior to adjuvant therapy may also be valuable in assessing regions of new CE and nonenhancing tumor...
  16. ncbi Potential value of MR spectroscopic imaging for the radiosurgical management of patients with recurrent high-grade gliomas
    Cynthia F Chuang
    Department of Radiation Oncology, University of California, San Francisco, Box 0226, San Francisco, CA 94143 0226, USA
    Technol Cancer Res Treat 6:375-82. 2007
    ....
  17. ncbi Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume
    Joonmi Oh
    Magnetic Resonance Science Center, Department of Radiology, University of California, San Francisco, California 94107, USA
    J Magn Reson Imaging 19:546-54. 2004
    ....
  18. ncbi 1H-MRSI of radiation effects in normal-appearing white matter: dose-dependence and impact on automated spectral classification
    Michael C Lee
    Magnetic Resonance Science Center, Department of Radiology, University of California San Francisco, San Francisco, California 94107 1739, USA
    J Magn Reson Imaging 19:379-88. 2004
    ..To identify radiation-induced changes in healthy white-matter spectra in the first six months following radiotherapy, and assess the impact of these changes on an automated algorithm for detecting spectral abnormalities...
  19. ncbi Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence
    Tracy R McKnight
    Department of Radiology, Biostatistics Core, Comprehensive Cancer Center, University of California, San Francisco 94143, USA
    J Neurosurg 97:794-802. 2002
    ..The information gleaned from the biopsy correlation study was used to test the hypothesis that there is metabolically active tumor in nonenhancing regions of the T2-hyperintense lesion that can be detected using MR spectroscopy...
  20. ncbi In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI
    Sarah J Nelson
    Mgnetic Resonance Science Center, Department of Radiology, University of California, San Francisco, California 94143, USA
    J Magn Reson Imaging 16:464-76. 2002
    ..Further work is required to integrate the results of the H-MRSI examination into the treatment planning workstation, and to improve the quality of the data using more sensitive phased array coils and higher field strength magnets...
  21. ncbi Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM
    Radhika Srinivasan
    Department of Radiology and Biomedical Imaging, 1700 4th Street, Byers Hall, Suite 301, San Francisco, CA 94143 2532, USA
    Neuro Oncol 12:1152-61. 2010
    ..Low levels of MCI for tumor were associated with a reduced apparent diffusion coefficient and elevated choline-N-acetyl-aspartate index derived from in vivo MR images...
  22. ncbi Adjuvant treatment of brain metastases
    F Lohr
    Department of Clinical Radiology, University of Heidelberg, Heidelberg, Germany frank
    Semin Surg Oncol 20:50-6. 2001
    ..However, RS is definitely an excellent option for salvage and palliation in patients with short life expectancy, as it is simultaneously noninvasive and cost-effective, with short hospitalization times...
  23. ncbi Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients
    Xiaojuan Li
    Department of Radiology, Magnetic Resonance Science Center, University of California-San Francisco, San Francisco, California 94143, USA
    J Magn Reson Imaging 16:229-37. 2002
    ..CONCLUSION: These 3D-MRSI data provide important additional information to conventional MRI for evaluating and characterizing gliomas...
  24. ncbi Comparison of intensity-modulated radiosurgery with gamma knife radiosurgery for challenging skull base lesions
    Jean L Nakamura
    Department of Radiation Oncology, University of California, San Francisco, School of Medicine, San Francisco, CA 94143, USA
    Int J Radiat Oncol Biol Phys 55:99-109. 2003
    ....
  25. ncbi Linac-based radiosurgery of cerebral melanoma metastases. Analysis of 122 metastases treated in 64 patients
    Klaus K Herfarth
    Division of Radiation Oncology, German Cancer Research Center, and Department of Radiation Oncology, University of Heidelberg, Germany
    Strahlenther Onkol 179:366-71. 2003
    ..We retrospectively analyzed patients with brain metastases of malignant melanoma who were treated at our institution for outcome and prognostic factors...